Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/08/2010EP2226078A2 Anti-fungual compounds and compositions
09/08/2010EP2226075A1 Material for preventing tissue adhesion and material for preventing joint contracture
09/08/2010EP2226074A2 Pharmaceutical compositions and their methods of use
09/08/2010EP2226073A1 Topical pharmaceutical composition comprising an antiseptic and arginine for wound healing
09/08/2010EP2226072A1 Combinations of suberoylanilide hydroxamic acid and antimetbolic agents for treating cancer
09/08/2010EP2226071A1 Composition for oral administration
09/08/2010EP2226070A1 Process for determining the optimal dosage of antivitamins K in anticoagulant therapy
09/08/2010EP2225957A1 Lupin oil based anti-oxidant and/or anti-elastase composition.
09/08/2010EP2225312A2 Method of preparing a material formed from branched molecules comprising associative groups
09/08/2010EP2225270A1 Methods and pharmaceutical compositions for regulation of g- and/or gc-rich nucleic acid expression
09/08/2010EP2225257A2 Preparation of 6-oxa-8alpha-steroid estrogen analogues - a new group of unnatural estrogens and their use in medicine
09/08/2010EP2225256A2 Novel glucocorticoid receptor agonists
09/08/2010EP2225254A1 Therapeutic cancer treatments
09/08/2010EP2225253A1 Phosphonic acid derivates and their use as p2y12 receptor antagonists
09/08/2010EP2225252A1 C2-c5-alkyl-imidazole-bisphosphonates
09/08/2010EP2225247A1 2-fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
09/08/2010EP2225246A1 Benzomorphan compounds
09/08/2010EP2225245A2 N-phenyl-imidazoý1,2-a¨pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
09/08/2010EP2225244A1 Imidazoý1,2-a¨pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics
09/08/2010EP2225243A2 Derivatives of n-heterocyclic-6-heterocyclic-imidazoýl,2- a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
09/08/2010EP2225242A2 Derivatives of n-heterocyclic-imidazoý1,2-a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
09/08/2010EP2225241A2 Derivatives of n-phenyl-imidazoý1,2-a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
09/08/2010EP2225240A2 Derivatives of 6-heterocyclic-imidazoýl,2-a¨pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof
09/08/2010EP2225238A1 Derivatives of 6,7-dihydro-5h-imidazoý1,2- ¨imidazole-3- carboxylic acid amides
09/08/2010EP2225235A2 Thiazole carboxamide derivatives and their use to treat cancer
09/08/2010EP2225233A1 Oxadiazole derivatives active on sphingosine-1-phosphate (s1p)
09/08/2010EP2225231A1 Aminotriazole derivatives as alx agonists
09/08/2010EP2225230A1 Solid forms of 3-(6-(1-(2,2-difluorobenzoýd¨ý1,3¨dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
09/08/2010EP2225229A1 Pyrazole derivatives as 5-lo inhibitors
09/08/2010EP2225228A2 Method of obtaining of 4-n-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-n-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition
09/08/2010EP2225227A2 Compounds
09/08/2010EP2225226A1 Compounds and method for treatment of cancer
09/08/2010EP2225225A2 Angiotensin ii receptor antagonists
09/08/2010EP2225224A2 Novel hemioxalate salt of eletriptan
09/08/2010EP2225223A2 Organic compounds
09/08/2010EP2225222A1 A quinoline derivative acting as a p2x7-receptor antagonist
09/08/2010EP2225217A2 Morpholines as selective inhibitors of cytochrome p450 2a13
09/08/2010EP2225216A1 Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders
09/08/2010EP2225215A1 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
09/08/2010EP2225214A1 Novel phenyl-acetamide and phenyl-propionamide derivatives useful as potassium channel modulators
09/08/2010EP2225212A1 Novel carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
09/08/2010EP2225211A1 Herbicidal pyridazinone derivatives
09/08/2010EP2225210A1 Dual-acting benzoimidazole derivative and their use as antihypertensive agents
09/08/2010EP2225201A2 Polymorphs of n-malonyl-bis(n'-methyl-n'-thiobenzoylhydrazide)
09/08/2010EP2225196A1 Cysteine protease inhibitors for the treatment of parasitic diseases
09/08/2010EP2224960A2 Method of treating cancer
09/08/2010EP2224956A1 Therapeutic targets and medicaments involving p230/golgin-245
09/08/2010EP2224950A1 Medicament for the treatment of cancer of the pancreas
09/08/2010EP2224939A2 Preparations with rosehip extracts, and method of producing rosehip extracts
09/08/2010EP2224933A2 Conjugated beta-1,3-linked glucans
09/08/2010EP2224931A2 Beta glycolipids for the treatment of calcification related degenerative disorders
09/08/2010EP2224930A1 Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing congnitive and related functions
09/08/2010EP2224929A1 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1
09/08/2010EP2224928A1 Novel seh inhibitors and their use
09/08/2010EP2224926A1 Prolyl hydroxylase inhibitors
09/08/2010EP2224925A1 Compounds for use in the treatment of cancer
09/08/2010EP2224924A1 Compositions and methods for treating cystic fibrosis
09/08/2010EP2224923A1 Compositions and methods for inhibiting cytochrome p450 2d6
09/08/2010EP2224922A2 Use of phthalimide and/or sulphonamide derivatives in the treatment of diseases which require reducing the tnf- levels and an exogenous source of nitric oxide, phthalimide derivatives, sulphonamide derivatives, and a method for obtaining a sulphonamide derivative
09/08/2010EP2224921A2 Modulation of the immune response
09/08/2010EP2224920A1 Process for making macrocyclic oximyl hepatitis c protease inhibitors
09/08/2010EP2224918A1 Use of edta and its derivatives for prevention and treatment of bacterial intestinal diseases of pigs and for increasing the effects of antibiotics exerted in such diseases
09/08/2010EP2224917A1 Compositions comprising nicotinic agonists and methods of using same
09/08/2010EP2224914A2 Rhein or diacerein compositions
09/08/2010EP2224913A1 Improved formulations and methods for lyophilization and lyophilates provided thereby
09/08/2010EP2224912A1 Improved compositions and methods for the delivery of nucleic acids
09/08/2010EP2224908A2 Compositions containing at least one naphthoic acid derivative, benzoyl peroxide and at least one film-forming agent, methods for preparing same and uses thereof
09/08/2010EP2224906A1 A method for producing adapalene gels
09/08/2010EP2224904A2 Intravesical compositions with valrubicin for the treatment of bladder cancer
09/08/2010EP2224812A2 Azolylmethyloxiranes, use thereof and agents containing the same
09/08/2010EP2224808A2 Pharmaceutical composition
09/08/2010EP2224805A1 Pharmaceutical composition
09/08/2010EP2224804A1 Treatment of cancer with combinations of topoisomerase inhibitors and parp inhibitors
09/08/2010EP2224803A1 Spiropiperidines for use as tryptase inhibitors
09/08/2010EP2224801A1 Macrocyclic oximyl hepatitis c serine protease inhibitors
09/08/2010EP2081921B1 Short-acting benzodiazepine salts and their polymorphic forms
09/08/2010EP2024367B1 Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
09/08/2010EP2007770B1 Imidazo compounds
09/08/2010EP1931659B1 Derivatives of 2 -aminthiazoles and 2-aminooxazoles, processes for their preparation and their use as pharmaceuticals
09/08/2010EP1919878B1 Pyridazinone derivatives as thyroid hormone receptor agonists
09/08/2010EP1915357B1 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the gaba-b-receptor
09/08/2010EP1901755B1 New pharmaceutical compositions containing hyaluronic acid or its derivatives and collagenase for the topical treatment of wounds, burns and ulcers
09/08/2010EP1874781B9 Dihydrothienopyrimidines for the treatment of inflammatory diseases
09/08/2010EP1841741B1 Piperidine derivatives as prodrugs of potassium channel inhibitors
09/08/2010EP1813610B1 Novel pyridonecarboxylic acid derivatives or salts thereof
09/08/2010EP1807431B1 Pyrrolo[1,2-d][1,2-4]triazine as inhibitors of c-jun n-terminal kinases (jnk) and p-38 kinases
09/08/2010EP1784407B1 2-arylmethylazetidine carbapenem derivatives and preparation thereof
09/08/2010EP1773811B1 A crystalline variable hydrate of (s)-6-(4-(2-((3-(9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinecarbox amide hemisuccinate salt
09/08/2010EP1758587B1 Use of a pharmaceutical composition comprising calcitriol and clobetasol propionate for the treatment of psoriasis
09/08/2010EP1713468B9 Anthelmintic composition
09/08/2010EP1644376B1 PYRROLO 3,4-c PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS
09/08/2010EP1641352B1 Compositions for improved oxidative status in cats
09/08/2010EP1638524B1 Composition and method for the treatment of water related ear disorders
09/08/2010EP1478624B1 Chemical compounds
09/08/2010EP1476171B1 Transportation of nucleic acid substances
09/08/2010EP1454903B1 Thiadiazoline derivatives for treating cancer
09/08/2010EP1429797B1 Diagnosis and treatment of malignant neoplasms
09/08/2010EP1406697B1 Use of magnesium for preventing in-stent thrombosis and complications after arterial angioplasty with stent placement
09/08/2010EP1399190B1 Pharmaceutical compositions comprising low-solubility and acid-sensitive drugs and neutralized acidic polymers
09/08/2010EP1388340B1 Compositions for transmucosal administration containing coenzyme q as the active ingredient
1 ... 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 ... 7860